Capula Management’s Apellis Pharmaceuticals APLS Stock Holding History

Capula Management’s Portfolio APLS Stock Details APLS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-56,266	Closed	-$2.26M	–	749
2026 Q1	$2.26M	Buy	+56,266	New	+$1.21M	0.02%	234

Other funds holding APLS

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Capula Management's APLS Position: Q2 2026 in Review

Capula Management sold out of Apellis Pharmaceuticals (APLS) in Q2 2026, closing a stake of 56,266 shares — an estimated $2.26M sold.

Capula Management first reported a position in APLS in Q1 2026 and held it in 1 quarter. The position peaked at $2.26M in Q1 2026. 1 fund tracked by Wall St. Rank holds APLS as of Q2 2026.

Capula Management reported no remaining Apellis Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
Capula Management sold 56,266 Apellis Pharmaceuticals shares in Q2 2026, an estimated $2.26M.
Capula Management first reported a position in Apellis Pharmaceuticals in Q1 2026 and held it in 1 quarter.
Capula Management's Apellis Pharmaceuticals position peaked at $2.26M in Q1 2026.
1 fund tracked by Wall St. Rank held Apellis Pharmaceuticals as of Q2 2026.

Based on Capula Management's 13F filing for Q2 2026, filed 14 Aug 2026.